(NASDAQ: BLLN) Billiontoone's forecast annual revenue growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 8.11%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.34%.
Billiontoone's revenue in 2026 is N/A.On average, 10 Wall Street analysts forecast BLLN's revenue for 2026 to be $21,278,890,763, with the lowest BLLN revenue forecast at $19,833,252,701, and the highest BLLN revenue forecast at $22,196,500,669. On average, 10 Wall Street analysts forecast BLLN's revenue for 2027 to be $26,932,195,701, with the lowest BLLN revenue forecast at $25,062,019,322, and the highest BLLN revenue forecast at $28,358,055,705.
In 2028, BLLN is forecast to generate $32,958,524,015 in revenue, with the lowest revenue forecast at $29,218,171,256 and the highest revenue forecast at $36,482,238,044.